Yeast killer toxins technology transfer

Mycotoxins in Food, Feed and Bioweapons

Volumn , Issue , 2010, Pages 275-290

  Magliani, Walter ^a   Conti, Stefania ^a   Giovati, Laura ^a   Polonelli, Luciano ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874246919     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-00725-5_16     Document Type: Chapter

References (71)

1. Beninati C, Oggioni MR, Boccanera M, Spinosa MR, Maggi T, Conti S, Magliani W, De Bernardis F, Teti G, Cassone A, Pozzi G, Polonelli L (2000) Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat Biotechnol 18:1060-1064
2. Bennett AM, Norris AR, Limnander de Nieuwenhove A, Russell PJ (2002) Replication of a linear mini-chromosome with terminal inverted repeats from the Kluyveromyces lactis linear DNA plasmid k2 in the cytoplasm of Saccharomyces cerevisiae. Plasmid 48:13-23
3. Bleve G, Grieco F, Cozzi G, Logrieco A, Visconti A (2006) Isolation of epiphytic yeasts with potential for biocontrol of Aspergillus carbonarius and A. niger on grape. Int J Food Microbiol 108:204-209
4. Brena S, Omaetxebarriá MJ, Elguezabal N, Cabezas J, Moragues MD, Pontón J (2007) Fungicidal monoclonal antibody C7 binds to Candida albicans Als3. Infect Immun 75:3680-3682
5. Bryden WL (2007) Mycotoxins in the food chain: human health implications. Asia Pac J Clin Nutr 16(Suppl 1):95-101
6. Buzzini P, Turchetti B, Vaughan-Martini AE (2007) The use of killer sensitivity patterns for biotyping yeast strains: The state of the art, potentialities and limitations. FEMS Yeast Res 7:749-760
7. Caprilli F, Prignano G, Latella C, Tavarozzi S (1985) Amplification of the killer system for differentiation of Candida albicans strains. Mykosen 28:569-573
8. Carrau FM, Neirotti E, Gioia O (1993) Stuck wine fermentations: effect of killer/sensitive yeast interactions. J Ferment Bioeng 76:67-69
9. Casadevall A, Pirofski LA (2007) Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma. Infect Immun 75:5074-5078
10. Casoli C, Pilotti E, Perno CF, Balestra E, Polverini E, Cassone A, Conti S, Magliani W, Polonelli L (2006) A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex-vivo HIV-1 replication. AIDS 20:975-980
11. Cenci E, Pericolini E, Mencacci A, Conti S, Magliani W, Bistoni F, Polonelli L, Vecchiarelli A (2006) Modulation of phenotype and function of dendritic cells by a therapeutic synthetic killer peptide. J Leukoc Biol 79:40-45
12. Ciani M, Fatichenti F (2001) Killer toxin of Kluyveromyces phaffii DBVPG 6076 as a biopreservative agent to control apiculate wine yeasts. Appl Environ Microbiol 67:3058-3063
13. Clausen M, Kräuter R, Schachermayr G, Potrykus I, Sautter C (2000) Antifungal activity of a virally encoded gene in transgenic wheat. Nat Biotechnol 18:446-449
14. Cohen ML (2000) Changing patterns of infectious disease. Nature 406:762-727
15. Comitini F, De Ingeniis J, Pepe L, Mannazzu I, Ciani M (2004) Pichia anomala and Kluyveromyces wickerhamii killer toxins as new tools against Dekkera/Brettanomyces spoilage yeasts. FEMS Microbiol Lett 238:235-240
16. Conti S, Magliani W, Gerloni M, Salati A, Dieci E, Arseni S, Fisicaro P, Polonelli L (1998) A transphyletic anti-infectious control strategy based on the killer phenomenon. FEMS Immunol Med Microbiol 22:151-161
17. Conti S, Magliani W, Giovati L, Libri I, Maffei DL, Salati A, Polonelli L (2008) Screening of a Saccharomyces cerevisiae nonessential gene deletion collection for altered susceptibility to a killer peptide. New Microbiol 31:157-159
18. Donini M, Lico C, Baschieri S, Conti S, Magliani W, Polonelli L, Benvenuto E (2005) Production of an engineered killer peptide in Nicotiana benthamiana by using a potato virus X expression system. Appl Environ Microbiol 71:6360-6367
19. Druvefors U, Jonsson N, Boysen ME, Schnürer J (2002) Efficacy of the biocontrol yeast Pichia anomala during long-term storage of moist feed grain under different oxygen and carbon dioxide regimens. FEMS Yeast Res 2:389-394
20. Eiden-Plach A, Zagorc T, Heintel T, Carius Y, Breinig F, Schmitt MJ (2004) Viral preprotoxin signal sequence allows efficient secretion of green fluorescent protein by Candida glabrata, Pichia pastoris, Saccharomyces cerevisiae, and Schizosaccharomyces pombe. Appl Environ Microbiol 70:961-966
21. Fanti F, Conti S, Campani L, Morace G, Dettori G, Polonelli L (1989) Studies on the epidemiology of Aspergillus fumigatus infections in a university hospital. Eur J Epidemiol 5:8-14
22. Fiori PL, Mattana A, Dess D, Conti S, Magliani W, Polonelli L (2006) In vitro acanthamoebicidal activity of a killer monoclonal antibody and a synthetic peptide. J Antimicrob Chemother 57:891-898
23. Fuentefria AM, Faganello J, Pazzini F, Schrank A, Valente P, Vainstein M (2007) Typing and patterns of cellular morphological alterations in Cryptococcus neoformans and Cryptococcus gattii isolates exposed to a panel of killer yeasts. Med Mycol 45:503-512
24. Gibbs MD, Reeves RA, Sunna A, Bergquist PL (2004) A yeast intron as a translational terminator in a plasmid shuttle vector. FEMS Yeast Res 4:573-577
25. Giga-Hama Y, Tohda H, Takegawa K, Kumagai H (2007) Schizosaccharomyces pombe minimum genome factory. Biotechnol Appl Biochem 46:147-155
26. Guyard C, Evrard P, Corbisier-Colson AM, Louvart H, Dei-Cas E, Menozzi FD, Polonelli L, Cailliez J (2001) Immuno-crossreactivity of an anti-Pichia anomala killer toxin monoclonal antibody with a Williopsis saturnus var. mrakii killer toxin. Med Mycol 39:395-400
27. Guyard C, Dehecq E, Tissier JP, Polonelli L, Dei-Cas E, Cailliez JC, Menozzi FD (2002) Involvement of [beta]-glucans in the wide-spectrum antimicrobial activity of Williopsis saturnus var. mrakii MUCL 41968 killer toxin. Mol Med 8:686-694
28. Heintel T, Zagorc T, Schmitt MJ (2001) Expression, processing and high level secretion of a virus toxin in fission yeast. Appl Microbiol Biotechnol 56:165-172
29. Izgü F, Altinbay D, Tü reli AE (2007a) In vitro susceptibilities of Candida spp. to Panomycocin, a novel exo-beta-1,3-glucanase isolated from Pichia anomala NCYC 434. Microbiol Immunol 51:797-803
30. Izgü F, Altinbay D, Türeli AE (2007b) In vitro activity of panomycocin, a novel exo-beta-1, 3-glucanase isolated from Pichia anomala NCYC 434, against dermatophytes. Mycoses 50:31-34
31. Komiyama T, Shirai T, Ohta T, Urakami H, Furuichi Y, Ohta Y, Tsukada Y (1998) Action properties of HYI killer toxin from Williopsis saturnus var. saturnus, and antibiotics, aculeacin A and papulacandin B. Biol Pharm Bull 21:1013-1019
32. Lowes KF, Shearman CA, Payne J, MacKenzie D, Archer DB, Merry RJ, Gasson MJ (2000) Prevention of yeast spoilage in feed and food by the yeast mycocin HMK. Appl Environ Microbiol 66:1066-1076
33. Magliani W, Conti S, De Bernardis F, Gerloni M, Bertolotti D, Mozzoni P, Cassone A, Polonelli L (1997a) Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat Biotechnol 15:155-158
34. Magliani W, Conti S, Gerloni M, Bertolotti D, Polonelli L (1997b). Yeast killer systems. Clin Microbiol Rev 10:369-400
35. Magliani W, Conti S, Salati A, Arseni S, Ravanetti L, Frazzi R, Polonelli L (2004a) Engineered killer mimotopes: new synthetic peptides for antimicrobial therapy. Curr Med Chem 11: 1793-800
36. Magliani W, Conti S, Salati A, Vaccari S, Ravanetti L, Maffei DL, Polonelli L (2004b) Therapeutic potential of yeast killer toxin-like antibodies and mimotopes. FEMS Yeast Res 5:11-18
37. Magliani W, Conti S, Frazzi R, Ravanetti L, Maffei DL, Polonelli L (2005) Protective antifungal yeast killer toxin-like antibodies. Curr Mol Med 5:443-452
38. Magliani W, Conti S, Maffei DL, Ravanetti L, Polonelli L (2007) Anti-idiotype-derived killer peptides as new potential tools to combat HIV-1 and AIDS-related opportunistic pathogens. Anti-Infective Agents Med Chem 6:263-272
39. Maia ML, Dos Santos JI, Viani FC, Larsson CE, Paula CR, Gambale W (2001) Phenotypic characterization of Microsporum canis isolated from cats and dogs. Mycoses 44:480-486
40. Marquina D, Santos A, Peinado JM (2002) Biology of killer yeasts. Int Microbiol 5:65-71
41. Matthews RC, Burnie JP (2005) Human recombinant antibody to HSP90: A natural partner in combination therapy. Curr Mol Med 5:403-411
42. Miyamoto M, Onozato N, Selvakumar D, Kimura T, Furuichi Y, Komiyama T (2006) The role of the histidine-35 residue in the cytocidal action of HM-1 killer toxin. Microbiology 152:2951-2958
43. Morace G, Archibusacci C, Sestito M, Polonelli L (1984) Strain differentiation of pathogenic yeasts by the killer system. Mycopathologia 84:81-85
44. Morace G, Manzara S, Dettori G, Fanti F, Conti S, Campani L, Polonelli L, Chezzi C (1989) Biotyping of bacterial isolates using the yeast killer system. Eur J Epidemiol 5:303-310
45. Morrison VA (2006) Echinocandin antifungals: review and update. Expert Rev Anti-Infect Ther 4:325-342
46. Passoth V, Fredlund E, Drufevors UA, Schnürer S (2006) Biotechnology, physiology and genetics of the yeast Pichia anomala. FEMS Yeast Res 6:3-13
47. Pérez F, Raḿrez M, Regodón JA (2001) Influence of killer strains of Saccharomyces cerevisiae on wine fermentation. Antonie van Leeuwenhoek 79:393-399
48. Pettoello-Mantovani M, Nocerino A, Polonelli L, Morace G, Conti S, Di Martino L, De Ritis G, Iafusco M, Guandalini S (1995) Hansenula anomala killer toxin induces secretion and severe acute injury in the rat intestine. Gastroenterology 109:1900-1906
49. Polonelli L, Morace G (1986) Reevaluation of the yeast killer phenomenon. J Clin Microbiol 24:866-869
50. Polonelli L, Morace G (1988) Yeast killer toxin-like anti-idiotypic antibodies. J Clin Microbiol 26:602-604
51. Polonelli L, Archibusacci C, Sestito M, Morace G (1983) Killer system: A simple method for differentiating Candida albicans strains. J Clin Microbiol 17:774-780
52. Polonelli L, Castagnola M, Rossetti DV, Morace G (1985) Use of killer toxins for computer-aided differentiation of Candida albicans strains. Mycopathologia 91:175-179
53. Polonelli L, Lorenzini R, De Bernardis F, Morace G (1986) Potential therapeutic effect of yeast killer toxin. Mycopathologia 96:103-107
54. Polonelli L, Conti S, Campani L, Morace G, Fanti F (1989) Yeast killer toxins and dimorphism. J Clin Microbiol 27:1423-1425
55. Polonelli L, Conti S, Gerloni M, Magliani W, Castagnola M, Morace G, Chezzi C (1991) 'Antibiobodies': antibiotic-like anti-idiotypic antibodies. J Med Vet Mycol 29:235-242
56. Polonelli L, Menozzi MG, Campani L, Gerloni M, Conti S, Morace G, Chezzi C (1992) Anaerobic yeast killer systems. Eur J Epidemiol 8:471-476
57. Polonelli L, Lorenzini R, De Bernardis F, Gerloni M, Conti S, Morace G, Magliani W, Chezzi C (1993) Idiotypic vaccination: immunoprotection mediated by anti-idiotypic antibodies with antibiotic activity. Scand J Immunol 37:105-110
58. Polonelli L, De Bernardis F, Conti S, Boccanera M, Gerloni M, Morace G, Magliani W, Chezzi C, Cassone A (1994) Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies. J Immunol 152:3175-3182
59. Polonelli L, De Bernadis F, Conti S, Boccanera M, Magliani W, Gerloni M, Cantelli C, Cassone A (1996) Human natural yeast killer toxin-like candidacidal antibodies. J Immunol 156: 1880-1885
60. Polonelli L, Séguy N, Conti S, Gerloni M, Bertolotti D, Cantelli C, Magliani W, Cailliez JC (1997) Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies. Clin Diagn Lab Immunol 4:142-146
61. Polonelli L, Magliani W, Conti S, Bracci L, Lozzi L, Neri P, Adriani D, De Bernardis F, Cassone A (2003) Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis. Infect Immun 71:6205-6212
62. Provost F, Polonelli L, Conti S, Fisicaro P, Gerloni M, Boiron P (1995) Use of yeast killer system to identify species of the Nocardia asteroides complex. J Clin Microbiol 33:8-10
63. Santos A, Marquina D (2004) Killer toxin of Pichia membranifaciens and its possible use as a biocontrol agent against grey mould disease of grapevine. Microbiology 150:2527-2534
64. Schlaich T, Urbaniak B, Plissonnier ML, Malgras N, Sautter C (2007) Exploration and Swiss fieldtesting of a viral gene for specific quantitative resistance against smuts and bunts in wheat. Adv Biochem Eng Biotechnol 107:97-112
65. Schmitt MJ, Breinig F (2006) Yeast viral killer toxins: lethality and self-protection. Nat Rev Microbiol 4:212-221
66. Séguy N, Cailliez JC, Polonelli L, Dei-Cas E, Camus D (1996) Inhibitory effect of a Pichia anomala killer toxin on Pneumocystis carinii infectivity to the SCID mouse. Parasitol Res 82:114-116
67. Selvakumar D, Miyamoto M, Furuichi Y, Komiyama T (2006) Inhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies. Antimicrob Agents Chemother 50:3090-3097
68. Theisen S, Molkenau E, Schmitt MJ (2000) Wicaltin, a new protein toxin secreted by the yeast Williopsis californica and its broad-spectrum antimycotic potential. J Microbiol Biotechnol 10:547-550
69. Torosantucci A, Bromuro C, Chiani P, De Bernardis F, Berti F, Galli C, Norelli F, Bellucci C, Polonelli L, Costantino P, Rappuoli R, Cassone A (2005) A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med 202:597-606
70. Van Vuuren HJJ, Jacobs CJ (1992) Killer yeasts in the wine industry: A review. Am J Enol Vitic 43:119-128
71. Yap NA, de Barros Lopes M, Langridge P, Henschke PA (2000) The incidence of killer activity of non-Saccharomyces yeasts towards indigenous yeast species of grape must: potential application in wine fermentation. J Appl Microbiol 89:381-389